Short answer
ASPEN AEROGELS INC (ASPN) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results announced for quarter ended June 30, 2026.
ASPEN AEROGELS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results announced for quarter ended June 30, 2026
- Business developments discussed alongside quarterly financial results
- Detailed results and metrics provided in Exhibit 99.1 press release
Item 7.01 · Regulation FD Disclosure
- Item 7.01 incorporates the press release’s “Financial Outlook” and company description into the disclosure record
- Investors should review the referenced exhibit for Aspen Aerogels’ latest outlook and operating expectations
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $49.8M, down from $78.0M, with Thermal Barrier revenue $29.5M, down 47% year over year
- Adjusted EBITDA $(6.6)M versus $9.7M, reflecting $5.3M of East Providence incident-related costs
- Q3 outlook improves materially: revenue $65M to $80M and adjusted EBITDA $7M to $15M
- European Thermal Barrier 2026 revenue outlook raised to $20M to $30M, supporting international growth momentum
- Liquidity $153.4M, while East Providence restart and insurance recovery collection remain key execution catalysts
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASPEN AEROGELS INC 8-K filings
Get the next ASPN 8-K as it lands
Follow ASPN for push alerts, or ask the research agent what this filing means.